Decision
point
DAY 0
ICU Admission
Decision point
Who is at risk of mucormycosis and why should
you suspect early?
There are several risk factors that need to be
considered when assessing patients' risk of
developing an IFI.
Which of the following risk factors increase
patients' risk for mucormycosis?
?
DAY 0(continued)
Liposomal Amphotericin B initiation
Diabetes1
Broad-spectrum antibiotic use2
Viral co-infections, such a influeza
and COVID-192-4
Corticosteroid use1
Mechanical ventilation1
Prolonged ICU stay3
All of these are risk factors that increase
patients' risk for mucormycosis.1–3,5
There are a number of factors that contribute to patients'
risk of developing an IFI, including many underlying
conditions, procedures/interventions (e.g. mechanical
ventilation), prolonged ICU stay and treatments such as
broad-spectrum antibiotics and corticosteroids.1
Decision
point
Decision point
?
DAY 0
ICU Admission
There are several risk factors that need to be considered when assessing patients' risk of developing an IFI.
Which of the following risk factors increase patients' risk for mucormycosis?
Who is at risk of mucormycosis and why should you
suspect early?
Diabetes1
Viral co-infections, such a influeza
and COVID-192-4
Mechanical ventilation1
Prolonged ICU stay3
Corticosteroid use1
Broad-spectrum antibiotic use2
DAY 0(continued)
Liposomal Amphotericin B initiation
All of these are risk factors that increase patients' risk for mucormycosis.1–3,5
There are a number of factors that contribute to patients' risk of developing an IFI, including many underlying conditions,
procedures/interventions (e.g. mechanical ventilation), prolonged ICU stay and treatments such as broad-spectrum antibiotics
and corticosteroids.1